Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Drug repositioning is a popular approach in the pharmaceutical industry for identifying potential new uses for existing drugs and accelerating the development time. Non-small-cell lung cancer (NSCLC) is one of the leading causes of death worldwide. To reduce the biological heterogeneity effects amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chien-Hung, Chang, Peter Mu-Hsin, Lin, Yong-Jie, Wang, Cheng-Hsu, Huang, Chi-Ying F., Ng, Ka-Lok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156989/
https://www.ncbi.nlm.nih.gov/pubmed/25210704
http://dx.doi.org/10.1155/2014/193817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156989/
https://www.ncbi.nlm.nih.gov/pubmed/25210704
http://dx.doi.org/10.1155/2014/193817

Ejemplares similares